(MENAFN- EIN Presswire) EINPresswire/ -- The global intraosseous infusion devices market is entering a steady growth phase, projected to expand from USD 5,446.2 million in 2026 to USD 11,248.6 million ...
PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
First three patients underwent successful implantation and clinical utilization of PortIO as part of a first-in-human study in Colombia, South America NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results